Basic information
- Full name
- activin A receptor type 1
- Ensembl
- ENSG00000115170.15
- Summary
- Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008]
- Annotation
- Cancer driver (Oncogene) Druggable target (Tier T3) Protein Kinase Receptor
Protein product
- ENST00000434821.7 Primary ENSP00000405004.1 (1 phosphosite)
- ENST00000263640.7
- ENST00000672582.1
- ENST00000673324.1
- ENST00000409283.6
- ENST00000424669.6
- ENST00000539637.6
- ENST00000410057.6
Phosphosites on the primary protein product
Tumor and normal comparison
Signed p-values | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Data type | Meta P | BRCA | CCRCC | COAD | GBM | HNSCC | LSCC | LUAD | OV | PDAC | UCEC |
RNA | 4.6e-23 | - | -2.7e-23 | - | - | 1.8e-17 | 2.3e-17 | 2.6e-21 | - | 1.1e-4 | - |
protein | 1.2e-6 | - | -0.018 | - | - | 1.1e-5 | 1.2e-17 | 1.5e-10 | -2.5e-3 | 0.011 | -2.6e-4 |
mRNA expression at gene level
Protein expression
Phenotype and mutation association
Manhattan plot summarizing associations of phenotypes and mutations across all cohorts and omics data types
Associations of the protein abundance of ACVR1 with phenotypes and mutations
Signed p-values | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Phenotype | Meta P | BRCA | CCRCC | COAD | GBM | HNSCC | LSCC | LUAD | OV | PDAC | UCEC | |
CTNNB1 mutation | 9.0e-6 | - | - | - | - | - | - | - | - | - | 9.0e-6 | |
HALLMARK_HEDGEHOG_SIGNALING | 3.9e-4 | 0.022 | -0.8 | - | 0.038 | 0.011 | 0.2 | -0.81 | 0.42 | -0.071 | 8.3e-5 | |
PROGENy: p53 | 6.6e-4 | 1.6e-3 | 0.41 | - | 0.99 | -0.76 | 0.23 | 0.094 | 0.43 | 0.11 | 0.22 | |
PROGENy: TGFb | 1.5e-3 | 0.031 | -0.076 | - | 0.98 | 1.3e-3 | 8.5e-3 | 0.95 | 0.89 | 0.44 | 0.022 | |
Tumor Purity (WGS) | 4.1e-3 | - | 0.7 | - | 0.95 | 0.093 | 0.79 | 0.31 | - | 0.74 | 1.2e-4 | |
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 4.3e-3 | 1.3e-3 | 0.93 | - | -0.038 | 0.022 | 5.8e-3 | 0.29 | -1 | 0.46 | 0.61 | |
HALLMARK_UV_RESPONSE_DN | 7.5e-3 | 1.9e-3 | -0.42 | - | 0.86 | 0.15 | 0.025 | 0.91 | -0.98 | -0.7 | 0.03 | |
KINASE-PSP_PKACA/PRKACA | 9.1e-3 | 0.011 | 0.31 | - | 0.51 | 0.9 | 0.052 | -0.56 | 0.98 | 0.011 | -0.64 | |
CTCF mutation | 0.01 | - | - | - | - | - | - | - | - | - | 0.01 | |
HALLMARK_NOTCH_SIGNALING | 0.014 | 0.02 | -0.13 | - | 0.42 | 2.7e-3 | 0.99 | 0.34 | -0.38 | 0.2 | 0.18 |
Cis-association
Associations between omics data of ACVR1
Trans-association
Associations of the protein abundance of ACVR1 and the protein abundance of other genes
Signed p-values | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene | Meta P | BRCA | CCRCC | COAD | GBM | HNSCC | LSCC | LUAD | OV | PDAC | UCEC | |
No matching records found |
Gene set enrichment analysis
Submit genes and the common logarithm of the p-values of their association with to WebGestalt.